176 related articles for article (PubMed ID: 28889377)
1. Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel.
Sjödahl G
Methods Mol Biol; 2018; 1655():53-64. PubMed ID: 28889377
[TBL] [Abstract][Full Text] [Related]
2. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
Sjödahl G; Eriksson P; Liedberg F; Höglund M
J Pathol; 2017 May; 242(1):113-125. PubMed ID: 28195647
[TBL] [Abstract][Full Text] [Related]
3. A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
Patschan O; Sjödahl G; Chebil G; Lövgren K; Lauss M; Gudjonsson S; Kollberg P; Eriksson P; Aine M; Månsson W; Fernö M; Liedberg F; Höglund M
Eur Urol; 2015 Nov; 68(5):824-32; discussion 835-6. PubMed ID: 25770486
[TBL] [Abstract][Full Text] [Related]
4. A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort.
Marzouka NA; Eriksson P; Rovira C; Liedberg F; Sjödahl G; Höglund M
Sci Rep; 2018 Feb; 8(1):3737. PubMed ID: 29487377
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of the luminal class of urothelial tumors.
Bernardo C; Eriksson P; Marzouka NA; Liedberg F; Sjödahl G; Höglund M
J Pathol; 2019 Nov; 249(3):308-318. PubMed ID: 31232464
[TBL] [Abstract][Full Text] [Related]
6. Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases.
Sjödahl G; Eriksson P; Lövgren K; Marzouka NA; Bernardo C; Nordentoft I; Dyrskjøt L; Liedberg F; Höglund M
Mod Pathol; 2018 Dec; 31(12):1869-1881. PubMed ID: 29967424
[TBL] [Abstract][Full Text] [Related]
7. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis.
Schallenberg S; Dragomir MP; Anders P; Ebner B; Volz Y; Eismann L; Rodler S; Casuscelli J; Buchner A; Klauschen F; Stief C; Horst D; Schulz GB
Eur Urol Focus; 2023 Sep; 9(5):788-798. PubMed ID: 37076398
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
Eriksson P; Aine M; Veerla S; Liedberg F; Sjödahl G; Höglund M
BMC Med Genomics; 2015 May; 8():25. PubMed ID: 26008846
[TBL] [Abstract][Full Text] [Related]
10. Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer.
van Rhijn BW
Urol Oncol; 2012; 30(4):518-23. PubMed ID: 22742564
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Dadhania V; Zhang M; Zhang L; Bondaruk J; Majewski T; Siefker-Radtke A; Guo CC; Dinney C; Cogdell DE; Zhang S; Lee S; Lee JG; Weinstein JN; Baggerly K; McConkey D; Czerniak B
EBioMedicine; 2016 Oct; 12():105-117. PubMed ID: 27612592
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours: An integrated immunohistochemical analysis.
Bernardo C; Eriksson P; Marzouka NA; Liedberg F; Sjödahl G; Höglund M
Hum Pathol; 2022 Apr; 122():11-24. PubMed ID: 35108518
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization of Neuroendocrine-like Bladder Cancer.
Batista da Costa J; Gibb EA; Bivalacqua TJ; Liu Y; Oo HZ; Miyamoto DT; Alshalalfa M; Davicioni E; Wright J; Dall'Era MA; Douglas J; Boormans JL; Van der Heijden MS; Wu CL; van Rhijn BWG; Gupta S; Grivas P; Mouw KW; Murugan P; Fazli L; Ra S; Konety BR; Seiler R; Daneshmand S; Mian OY; Efstathiou JA; Lotan Y; Black PC
Clin Cancer Res; 2019 Jul; 25(13):3908-3920. PubMed ID: 30952638
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and Immunohistochemical Study of Combined Small Cell Carcinoma and Urothelial Carcinoma Molecular Subtype.
Xiao GQ; Barrett MM; Yang Q; Unger PD
Pathol Oncol Res; 2019 Jul; 25(3):889-895. PubMed ID: 29249035
[TBL] [Abstract][Full Text] [Related]
15. HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts.
Eriksson P; Sjödahl G; Chebil G; Liedberg F; Höglund M
Oncotarget; 2017 Jul; 8(30):48905-48914. PubMed ID: 28388586
[TBL] [Abstract][Full Text] [Related]
16. [Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets].
Mikhailenko DS; Nemtsova MV
Urologiia; 2016 Feb; (1):100-105. PubMed ID: 28247712
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants.
Warrick JI; Sjödahl G; Kaag M; Raman JD; Merrill S; Shuman L; Chen G; Walter V; DeGraff DJ
Eur Urol; 2019 Jan; 75(1):18-22. PubMed ID: 30266310
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer.
McConkey DJ; Choi W; Ochoa A; Siefker-Radtke A; Czerniak B; Dinney CP
Hematol Oncol Clin North Am; 2015 Apr; 29(2):377-94, x-xi. PubMed ID: 25836941
[TBL] [Abstract][Full Text] [Related]
19. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiation Therapy.
Tanaka H; Yoshida S; Koga F; Toda K; Yoshimura R; Nakajima Y; Sugawara E; Akashi T; Waseda Y; Inoue M; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Saito K; Kihara K; Fujii Y
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1408-1416. PubMed ID: 29960059
[TBL] [Abstract][Full Text] [Related]
20. Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder.
Dubosq F; Ploussard G; Soliman H; Turpin E; Latil A; Desgrandchamps F; de The H; Mongiat-Artus P
Urol Oncol; 2012; 30(6):833-40. PubMed ID: 21489836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
